This aspect of our study might reveal preliminary associations in MDD and allow for the exploration of the potential predictive value of total apelin levels with respect to the presence of depressive symptoms as well as to their degree of severity, thereby providing insights that could guide researchers towards considering apelin as a biomarker in clinical settings. The gene discussed is APLN; the disease is major depressive disorder.